Preventive therapy with galcanezumab for two consecutive cluster bouts in patients with episodic cluster headache: an observational multicenter study

Abstract Background Cluster headache is a severe and disabling primary headache disorder. Galcanezumab is a monoclonal antibody against calcitonin gene-related peptide and a preventive therapy for episodic cluster headache. However, the approval and insurance coverage for episodic cluster headache d...

Full description

Bibliographic Details

Published in:	The Journal of Headache and Pain
Main Authors:	Yooha Hong, Mi-Kyoung Kang, Heui-Soo Moon, Byung-Kun Kim, Soo-Jin Cho
Format:	Article
Language:	English
Published:	BMC 2023-10-01
Subjects:	Cluster headache Cluster bout Calcitonin gene-related peptide Episodic Galcanezumab Preventive treatment
Online Access:	https://doi.org/10.1186/s10194-023-01661-7